Streetbeat News

Stock Prices

EVC

Entravision Comms (NYSE:EVC) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $0.07. The company's past earnings performance shows mixed results, with a notable miss last quarter but a subsequent 7.87% increase in share price. Over the last year, EVC shares have declined by 44.72%, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

MCRB

Seres Therapeutics (NASDAQ:MCRB) is anticipated to report a Q4 earnings per share (EPS) of $-0.50 on March 5, 2024. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, Seres Therapeutics has had a mixed performance in beating EPS estimates, with a notable 39.43% share price increase following last quarter's earnings beat. However, the stock has experienced a significant 78.52% decline over the past year, indicating potential investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

MRNS

Marinus Pharma (NASDAQ:MRNS) is expected to report a Q4 earnings per share (EPS) of $-0.62 on March 5, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Marinus Pharma's share price has reacted to both its earnings performance and the guidance provided. Last quarter, the company beat the EPS estimate by $0.05, leading to a 5.91% increase in share price the following day. Over the last year, MRNS shares have risen by 38.14%, with the stock trading at $9.92 as of March 1.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

SEAT

Vivid Seats (NASDAQ:SEAT) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $0.06. The company's past performance shows a pattern of beating EPS estimates, which has previously led to positive stock price movements. However, shares have declined by 20.36% over the last 52 weeks. Investors will be keenly watching for both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

ALNT

Allient (NASDAQ:ALNT) is expected to report an EPS of $0.32 in its upcoming quarterly earnings on 2024-03-05. Historically, the company's share price has reacted negatively to past earnings reports, despite beating EPS estimates. Shares are currently trading at $29.07, down 31.7% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

VTOL

Bristow Group (NYSE:VTOL) is scheduled to release its quarterly earnings report on March 5, 2024, with an estimated EPS of $0.54. Despite past earnings misses, the stock price increased after the last report. Shares are currently trading at $27.27, with a slight decline over the past year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

ELF

Market whales have shown a bearish stance on e.l.f. Beauty (NYSE:ELF), with unusual options activity indicating a split sentiment of 31% bullish and 68% bearish. The options trades target a price range of $100.0 to $290.0 for ELF. The company's stock is currently down by -4.15%, with a trading volume of 647,808 and an RSI suggesting it may be approaching overbought. Analysts have mixed ratings, with target prices ranging from $167 to $225.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

GLRE

Greenlight Capital Re (NASDAQ:GLRE) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $0.42. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares have risen 23.56% over the last 52 weeks, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

LLY

Eli Lilly and Co (NYSE:LLY) has seen significant options trading activity, with a bearish sentiment prevailing among financial giants. Analysis revealed 80 unusual trades, with 35% bullish and 65% bearish. Notable trades include a mix of puts and calls, targeting a price range of $420.0 to $1000.0. The company, specializing in neuroscience, cardiometabolic, cancer, and immunology drugs, is currently trading at $798.28, up 2.07%, but may be overbought according to RSI readings. Analysts have set an average target price of $816.0, with varying ratings from Overweight to Hold.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm

PKOH

Park-Ohio Hldgs (NASDAQ:PKOH) is scheduled to release its quarterly earnings report on 2024-03-05, with analysts estimating an EPS of $0.55. The company's historical performance shows a pattern of beating EPS estimates, leading to significant share price movements. Last quarter, PKOH beat the EPS estimate by $0.19, resulting in a 21.3% share price increase the following day. Over the last 52 weeks, PKOH shares have risen by 88.36%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:02 pm